RB
The startup specializes in the development of transfection reagents and delivery systems for transporting nucleic acids into human cells, with a focus on blood cancers and immune cell modification. By enhancing the delivery of therapeutic nucleic acids, the company enables more effective treatments for patients with these conditions.
Updated 18 months ago
Funding
$510K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BM
Funding rounds are not available yet.
Founders
Product
Features
- The startup specializes in the development of transfection reagents and delivery systems for transporting nucleic acids into human cells, with a focus on blood cancers and immune cell modification. By enhancing the delivery of therapeutic nucleic acids, the company enables more effective treatments for patients with these conditions.